In arthritis, ERK1/2 activation levels are frequently markedly elevated, which may be related to the growth of inflammatory cells, the production of inflammatory mediators, and damage to the tissues of the joints (Marotte et al., 2010). This evidence concerns the gene MAPK3 and arthritic joint disease.